CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong
· Delayed Price · Currency is HKD 0.1620
+0.0260 (19.12%)
Jun 2, 2025, 3:59 PM HKT
CANbridge Pharmaceuticals Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | -442.62 | -378.84 | -483.48 | -1,077 | -846.04 | Upgrade
|
| Depreciation & Amortization | 27.16 | 28.34 | 21.92 | 15.67 | 17.82 | Upgrade
|
| Other Amortization | 0.09 | 0.12 | 0.06 | 0.03 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.23 | 2.01 | 1.25 | -9.73 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 89.41 | 4.01 | - | - | - | Upgrade
|
| Stock-Based Compensation | 7.69 | 19.92 | 26.82 | 30.51 | 14.66 | Upgrade
|
| Other Operating Activities | 15.63 | 18.13 | 33.5 | 430.43 | 615.9 | Upgrade
|
| Change in Accounts Receivable | 14.64 | -12.17 | -9.91 | -2.1 | -6.6 | Upgrade
|
| Change in Inventory | 0.88 | 1.04 | 3.62 | -12.9 | 0.07 | Upgrade
|
| Change in Accounts Payable | 165.09 | 90.51 | 63.93 | -3.11 | 40.59 | Upgrade
|
| Change in Other Net Operating Assets | 1.87 | -51.3 | 61.31 | 41.12 | 11.95 | Upgrade
|
| Operating Cash Flow | -122.4 | -278.23 | -280.98 | -587.07 | -151.65 | Upgrade
|
| Capital Expenditures | -0.11 | -5.14 | -15.2 | -5.09 | -2.57 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.03 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -35.33 | -0.14 | 131.18 | -150.91 | Upgrade
|
| Other Investing Activities | - | -0.38 | -19.45 | - | - | Upgrade
|
| Investing Cash Flow | 13.93 | -26.86 | -34.79 | 126.09 | -153.48 | Upgrade
|
| Long-Term Debt Issued | 27.93 | 19.8 | 38.63 | 20.76 | 21.53 | Upgrade
|
| Long-Term Debt Repaid | -45.08 | -45.77 | -43.31 | -32.08 | -18.07 | Upgrade
|
| Net Debt Issued (Repaid) | -17.15 | -25.97 | -4.68 | -11.32 | 3.46 | Upgrade
|
| Issuance of Common Stock | 0.04 | 0.08 | 0.03 | 563.8 | 0.99 | Upgrade
|
| Other Financing Activities | -1.45 | -2.13 | -16.06 | -33.07 | 9.11 | Upgrade
|
| Financing Cash Flow | -18.57 | -28.02 | -20.7 | 854.31 | 679.26 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.05 | 6.85 | 41.81 | -8.32 | -27.2 | Upgrade
|
| Net Cash Flow | -126.99 | -326.26 | -294.66 | 385.01 | 346.93 | Upgrade
|
| Free Cash Flow | -122.5 | -283.38 | -296.18 | -592.16 | -154.22 | Upgrade
|
| Free Cash Flow Margin | -143.94% | -275.47% | -375.04% | -1900.31% | -1281.74% | Upgrade
|
| Free Cash Flow Per Share | -0.29 | -0.67 | -0.70 | -6.28 | -2.25 | Upgrade
|
| Cash Interest Paid | 1.45 | 1.49 | 2.17 | 1.38 | 4.99 | Upgrade
|
| Levered Free Cash Flow | 16.48 | -202.09 | -142.04 | -207.98 | -225.19 | Upgrade
|
| Unlevered Free Cash Flow | 21.84 | -196.5 | -137.75 | -206.05 | -222.82 | Upgrade
|
| Change in Net Working Capital | -199.83 | -24.69 | -115.02 | -31.11 | -42.85 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.